Mannitol Intravenous Infusion BP 20% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

mannitol intravenous infusion bp 20% w/v solution for infusion

baxter healthcare limited - mannitol - solution for infusion - 20 percent weight/volume - solutions producing osmotic diuresis; mannitol

OSMITROL Mannitol 100g/L injection AHB3026 Australia - English - Department of Health (Therapeutic Goods Administration)

osmitrol mannitol 100g/l injection ahb3026

baxter healthcare pty ltd - mannitol, quantity: 100 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - osmitrol intravenous infusion (mannitol intravenous infusion, bp) can be used in: the promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; the reduction of intraocular pressure when the pressure cannot be lowered by other means; the reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; promoting the urinary excretion of toxic substances.

MANNITOL INTRAVENOUS INFUSION BP 20% W/V Kenya - English - Pharmacy and Poisons Board

mannitol intravenous infusion bp 20% w/v

medisel kenya ltd p.o box 540-01000, thika - mannitol bp - infusion - mannitol bp 20 gm - mannitol

Mannitol Intravenous Infusion BP (20 % w/v) 20M Solution For Infusion Kenya - English - Pharmacy and Poisons Board

mannitol intravenous infusion bp (20 % w/v) 20m solution for infusion

claris otsuka private limited survey no. 199 to 201 & 208 to 210, village - mannitol bp - solution for infusion - 20%wv - intravenous solutions: solutions producing

MANNITOL injection, solution United States - English - NLM (National Library of Medicine)

mannitol injection, solution

b. braun medical inc. - mannitol (unii: 3owl53l36a) (mannitol - unii:3owl53l36a) - mannitol 20 g in 100 ml - mannitol injection is indicated for: - reduction of intracranial pressure and treatment of cerebral edema. - reduction of elevated intraocular pressure. mannitol injection is contraindicated in patients with: - hypersensitivity to mannitol [see warnings and precautions (5.1)] - anuria [see warnings and precautions (5.2)] - severe hypovolemia [see warnings and precautions (5.4)] - pre-existing severe pulmonary vascular congestion or pulmonary edema [see warnings and precautions (5.5)] -   active intracranial bleeding except during craniotomy. the available case report data with mannitol over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.  mannitol crosses the placenta and may cause fluid shifts that could potentially result in adverse effects in the fetus (see data) .  no adverse developmental effects from mannitol were reported in published animal studies; however, fluid shifts occurred in fetal ewes in response to maternal

Mannitol 20% Malta - English - Medicines Authority

mannitol 20%

demo s.a. pharmaceutical industry 21st km national road athens - lamia 14568 krioneri, greece - mannitol - solution for infusion - mannitol 200 mg/l - blood substitutes and perfusion solutions

Mannitol 20% IV Infusion Bangladesh - English - DGDA (Directorate General of Drug Administration)

mannitol 20% iv infusion

libra infusion limited - mannitol - iv infusion - 20 gm/100 ml

MANNITOLVIOSER SOLUTION FOR INFUSION 20 % Israel - English - Ministry of Health

mannitolvioser solution for infusion 20 %

eldan electronic instruments co ltd, israel - mannitol - solution for infusion - mannitol 200 mg/ml - mannitol - mannitol 20%, solution for infusion is indicated for: - the promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; - the reduction of intracranial pressure and treatment of cerebral edema by reducing brain mass; - the reduction of elevated intraocular pressure when the pressure cannot be lowered by other means, and promoting the urinary excretion of toxic substances

Polyfusor mannitol 20% infusion 500ml bottles United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

polyfusor mannitol 20% infusion 500ml bottles

fresenius kabi ltd - mannitol - infusion - 200mg/1ml

BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 29.8 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.